Influence of excipients and processing conditions on the development of agglomerates of racecadotril by crystallo‑co‑agglomeration

ABSTRACT

Purpose:The purpose of the present investigation was to improve the flow and mechanical properties of racecadotril by a crystallo‑co‑agglomeration (CCA) technique. Direct tableting is a requirement of pharmaceutical industries. Poor mechanical properties of crystalline drug particles require wet granulation which is uneconomical, laborious, and tedious. Materials and Methods: The objective of this work was to study the influence of various polymers/excipients and processing conditions on the formation of directly compressible agglomerates of the water‑insoluble drug, racecadotril, an antidiarrheal agent. The agglomerates of racecadotril were prepared using dichloromethane (DCM)—water as the crystallization system. DCM acted as a good solvent for racecadotril as well as a bridging liquid for the agglomeration of the crystallized drug and water as the nonsolvent. The prepared agglomerates were tested for micromeritic and mechanical properties. Results: The process yielded ~90 to 96% wt/ wt spherical agglomerates containing racecadotril with the diameter between 299 and 521 μ. A higher rotational speed of crystallization system reduces the size of the agglomerates and disturbs the sphericity. Spherical agglomerates were generated with a uniform dispersion of the crystallized drug. CCA showed excellent flowability and crushing strength. Conclusion:Excipients and processing conditions can play a key role in preparing spherical agglomerates of racecadotril by CCA, an excellent alternative to the wet granulation process to prepare intermediates for direct compression.

KEYWORDS

• Crystallo‑co‑agglomeration
• crushing strength
• flowability
• racecadotril

Showing references and in-text citations exactly as published.

• DOI10.4103/2230-973X.106996Copy

RELATED ARTICLES

Matched on section and article type within this issue of IJPI.

• Article · VOLUME 2, ISSUE 4Formulation and optimisation of raft‑forming chewable tablets containing H2 antagonistShailesh T Prajapati, Anant P Mehta, Ishan P Modhia, Chhagan N Patel · pp. 176–182Original Research ArticleSame type: Article
• Article · VOLUME 2, ISSUE 4Formulation and evaluation of carvedilol melt‑in‑mouth tablet using mucoadhesive polymer and PEG‑6‑stearate as hydrophilic waxy binderAmish Ashvinkumar Dangi, Prakash Bhikhabhai Zalodiya · pp. 183–188Original Research ArticleSame type: Article
• Article · VOLUME 2, ISSUE 4Formulation and evaluation of Ketoconazole niosomal gel drug delivery systemSB Shirsand, MS Para, D Nagendrakumar, KM Kanani, D Keerthy · pp. 201–207Original Research ArticleSame type: Article
• Article · VOLUME 2, ISSUE 4Development of time controlled chronomodulated tablet with swelling and rupturable layers: Optimization of factors influencing lag‑time and drug releaseMayur Desai, Rishad R Jivani, Laxman D Patel, Noordin P Jivani, Bhavin Sonagara · pp. 208–212Original Research ArticleSame type: Article